Before you begin, please read these Abstract Instructions for details of the Abstract Structure, Abstract Submission Process, and awards and grants available. For more information contact the CSCC Office at email@example.com or call +1-613-531-8899.
Abstracts must be submitted online. The deadline for submission is February 29, 2020.
Confirmation will be sent on receipt of abstract. Notification of acceptance will be returned to the submitting author by March 31, 2020. Additional instructions for presentation will be provided at that time.
Abstracts submitted to the Annual Conference of the CSCC must meet approved standards for scientific quality and consistency, and they must be submitted correctly. They will be evaluated by peer review by one or more reviewers with expertise on the abstract topic. Failure to comply with the submission guidelines will result in request to resubmit with corrections or abstract rejection. Accepted abstracts are published in Clinical Biochemistry. Abstract data must not have been previously published in a copyrighted journal.
There is a no limit on the number of abstracts a person may submit. However, multiple abstracts must differ sufficiently to warrant separate presentations. Submission of multiple abstracts with similar content may result in the rejection of one or more of the abstracts.
Abstracts will be automatically rejected if they do not meet the following criteria:
Use sentence case (Capitalize first word and remaining words begin in lower case)
Include the authors and affiliations at the start of the body of the abstract in the following style:
First Name, space, Middle Initial(s), period, space, Surname, comma, space, followed by next author in same format.
Underline the name of the presenting author.
Indicate all affiliations with a lower-case superscript letter immediately after the author’s name and in front of the appropriate address.
Anne L. Smitha, Robert G. Davisa,b
aLaboratory Medicine and Pathobiology, University of Toronto, Toronto, ON
bLaboratory Medicine, University of Alberta Hospital, Edmonton, AB
Bold and Indented. Indent all paragraphs.
Times New Roman or Arial (Size 10).
250 words (not including title, authors and affiliations, keywords). Deduct 50 for each table or graphic.
The abstract must fit a width of 14 cm (5.5 inches) and a length of 10 cm or (4 inches). Using 10 point and a 8.5″x11″ page, set the margins for Top 1″, Bottom 6″, Left 1.5″, Right 1.5″. The entire text of the abstract, including title, name of authors, and author affiliations must be contained within these limits.
Maximum of 2 within the specified dimensions:
• Figures – upload the file using the graphic insert function.
• Tables – use wysiwyg to insert a table in the body of the abstract. Tables may not exceed 6 columns.
Objectives: / Design and Methods: / Results: / Conclusions:
Objectives – Sufficient information demonstrating relevance to clinical laboratory medicine.
Design and Methods – Sufficient description of methodology.
Results – Sufficient objective evidence in the results section to support conclusions. Results are to be expressed in IFCC SI units. The type of information will vary by study design, and the following should be included when appropriate:
a. Study Type: Development/Evaluation of new method/procedure
– Measuring range, linearity, precision (within-run and total), accuracy (comparison with accepted method and/or recovery studies)
– Interferences, cross-reactivity (especially if comparable method has these issues)
b. Study Type: Clinical
– Reference intervals and/or decision limits
– Diagnostic accuracy (clinical sensitivity and specificity, areas under ROC curves…)
c. Other Study Types
– Description of process
– Inputs (time, dollars, information…) and outputs (outcomes, productivity…)
– Statistical analysis
– Outcome comparison to comparable or original process/product
Conclusions – Provide a statement.
Keywords – Maximum 5 keywords.